Sorafenib-induced hand-foot syndrome

Sorafenib-induced hand-foot syndrome

Bibliographic Details
Main Authors:	Chaturbhuj Agrawal, Parveen Jain, Rajeev Saini, Pankaj Goyal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Archives of Medicine and Health Sciences
Online Access:	http://www.amhsjournal.org/article.asp?issn=2321-4848;year=2017;volume=5;issue=1;spage=137;epage=138;aulast=Agrawal

Similar Items

Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol
by: Serkan Demirkan, MD, et al.
Published: (2017-07-01)

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth
by: Kamimura K, et al.
Published: (2018-04-01)

Sorafenib induced hand-foot skin reaction at low dose
by: Vrutika H Shah, et al.
Published: (2020-01-01)

Management of cytotoxic chemotherapy-induced hand-foot syndrome
by: Johannes J.M. Kwakman, et al.
Published: (2020-05-01)

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib
by: Yarchoan Robert, et al.
Published: (2010-07-01)

Capecitabine Induced Hand-Foot Syndrome—A Case Report
by: D. A. Ndoli, et al.
Published: (2020-09-01)

An unusual and severe case of paclitaxel‐induced hand‐foot syndrome
by: Ichrak Ben Abdallah, et al.
Published: (2021-01-01)

Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
by: Jayastu Senapati, et al.
Published: (2014-02-01)

Hand-foot syndrome due to capecitabine
by: Surjushe Amar, et al.
Published: (2009-01-01)

Nasal involvement in hand and foot syndrome
by: Anil Mishra, et al.
Published: (2013-01-01)

Hand-foot syndrome due to capecitabine
by: Surjushe Amar, et al.
Published: (2008-01-01)

Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
by: Enxin Wang, et al.
Published: (2019-04-01)

Only 9 weeks or complete 12 months of adjuvant trastuzumab in Indian early-stage breast cancer patients: Is it the practice-changing approach in a resource-constrained setting?
by: Chaturbhuj R Agrawal, et al.
Published: (2020-01-01)

Gemcitabine and docetaxel combination chemotherapy induced dermatomyositis associated with hand-foot syndrome
by: Mayuko Kawada, et al.
Published: (2021-01-01)

Docetaxel-induced hand and foot syndrome in a patient with metastatic breast carcinoma
by: Ravichandran Gurumurthi, et al.
Published: (2013-01-01)

A Case of Sorafenib-induced DRESS Syndrome in Hepatocelluar Carcinoma
by: Dong Kyun Kim, et al.
Published: (2016-06-01)

Increased cumulative doses and appearance of hand-foot skin reaction prolonged progression free survival in sorafenib-treated advanced hepatocellular carcinoma patients
by: Wen-Tsan Chang, et al.
Published: (2018-07-01)

Conjecture about Hand-Foot Syndrome in CLASSIC Trial.
by: Guo-Sheng Wang
Published: (2014-04-01)

Hand-foot syndrome due to hepatitis C therapy
by: Marlone Cunha-Silva, et al.

Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish
by: Chen YH, et al.
Published: (2014-07-01)

Sorafenib-induced pemphigus vulgaris
by: Ajay Deshpande
Published: (2016-01-01)

Sorafenib-induced acute pancreatitis
by: Han-En Wang, et al.
Published: (2014-01-01)

As Clinical Markers, Hand-Foot-Skin Reaction and Diarrhea Can Predict Better Outcomes for Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization plus Sorafenib
by: Lei Liu, et al.
Published: (2019-01-01)

Allergens in hand, foot, and hand–Foot eczema: An intercomparison by patch testing
by: S Sahana, et al.
Published: (2021-01-01)

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients
by: Emel Emine Kayikci, et al.
Published: (2020-10-01)

Hand-foot syndrome with docetaxel : A five-case series
by: Farhat Mirna, et al.
Published: (2008-01-01)

Rational design of topical formulations for hand-foot syndrome management
by: Diva Maria Ferraz da Silva
Published: (2019)

Rational design of topical formulations for hand-foot syndrome management
by: Diva Maria Ferraz da Silva
Published: (2021)

Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma
by: Sardar Zakariya Imam, et al.
Published: (2020-09-01)

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
by: Shaoyan Lin, et al.
Published: (2019-10-01)

Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
by: Hu X, et al.
Published: (2021-01-01)

Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
by: Shiori Hiromoto, et al.
Published: (2021-04-01)

A rare case of lung adenocarcinoma: Unusual presentation with miliary mottling
by: Pankaj Goyal, et al.
Published: (2020-01-01)

Falls and Physical Inactivity in Patients with Gastrointestinal Cancer and Hand–Foot Syndrome
by: Hiroko Komatsu, et al.
Published: (2018-01-01)

Classical Hand, Foot and Mouth Disease Replaced by Atypical Hand, Foot and Mouth Disease
by: Regina Fölster-Holst
Published: (2018-02-01)

SkIndia Quiz 17: Linear dermatoses over the hand and foot
by: Varadraj V Pai, et al.
Published: (2015-01-01)

Hand, foot and mouth disease
by: Radhika Muppa, et al.
Published: (2011-01-01)

Oral lichen sclerosus in a breast cancer patient on anastrozole therapy: A case report with brief review of literature
by: Chaturbhuj Agrawal, et al.
Published: (2017-01-01)

Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review.
by: Min Chen, et al.
Published: (2013-01-01)

Using syndromic surveillance for early detection of hand-foot-mouth diseases epidemics
by: L. Tan, et al.
Published: (2014-04-01)